Print Email Facebook Twitter Release Share Font Size: A A A A
$10,000 to Vancouver researcher
Cancer detection research funded by life-science firm
Friday, Aug. 17, 2012
By Brenda Alling, WSU Vancouver
VANCOUVER, Wash. – Jie Xu, assistant professor in the School of Engineering and Computer Science at Washington State University Vancouver, has received $10,000 from TeloVISION LLC to support cancer-related research in the field of micro/nanofluidics.
"I plan to use the $10,000 to develop a microfluidic device using nanotechnologies,” Xu said. "We hope this tiny device with specially engineered structures and properties will be able to separate cancer cells from blood cells.
"If successful, this technology may be used in point-of-care and clinical settings for cancer detection,” he said.
Xu is a well-recognized researcher in the field of micro/nanofluidics for biomedical applications. TeloVISION is sponsoring Xu’s research into microfluidic device for cell separation in hopes of one day providing the gold standard of cancer diagnosis and prognosis.
TeloVISION is a life-science company based in West Lafayette, Ind., that provides physicians and cancer researchers with point-of-care solutions and technologies for rapid and inexpensive cancer diagnosis and therapeutic monitoring.
Xu has authored more than 60 important journal and conference publications. He was the 2011 Defense Advanced Research Projects Agency Young Faculty Investigator, 2011 National New Faces of Engineering and 2009 Chinese Government awardee.